Immunohistochemical expression status of four biomarkers; hormone receptors [estrogen receptor (ER), progesterone receptor (PR)], human epidermal growth factor receptor (HER2), and Ki-67, are key determinants of breast cancer molecular subtyping [2]. Here, NR4A1 is linked to breast cancer.